RAISECOM(SH:603803)2022-04-27 16:00Financial Performance - The company's operating revenue for Q1 2022 was CNY 430,212,659.98, representing a year-on-year increase of 24.54%[5] - The net profit attributable to shareholders for the same period was CNY 28,003,874.02, with a net profit excluding non-recurring gains and losses of CNY 27,312,300.31[5] - The basic and diluted earnings per share for Q1 2022 were both CNY 0.07[6] - The company's net profit for Q1 2022 was ¥28,054,532.29, a significant recovery from a net loss of ¥6,617,184.05 in Q1 2021, marking a turnaround of over 500%[18] - Operating profit for Q1 2022 reached ¥28,320,750.82, compared to an operating loss of ¥6,686,252.63 in the same period last year, indicating a strong operational performance[18] - Total comprehensive income for Q1 2022 was ¥26,870,629.80, compared to a loss of ¥6,310,631.03 in the previous year, reflecting a positive shift in overall financial health[19] - The company reported sales revenue of ¥482,963,457.65 in Q1 2022, an increase from ¥402,848,995.70 in Q1 2021, representing a growth of approximately 19.9%[20] Cash Flow - The net cash flow from operating activities increased by 118.59% to CNY 32,839,942.57, attributed to increased collections during the reporting period[9] - Cash flow from operating activities generated a net inflow of ¥32,839,942.57, a substantial improvement from a net outflow of ¥176,621,004.80 in Q1 2021[22] - Total cash inflow from operating activities was $637,070,192.62, while cash outflow was $575,315,063.93, resulting in a net increase of $61,755,128.69[30] - The company reported cash received from other operating activities amounting to $152,062,956.65 in Q1 2022, compared to $15,323,728.31 in Q1 2021[30] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,965,407,772.55, a decrease of 5.52% compared to the end of the previous year[6] - The total liabilities as of March 31, 2022, were RMB 1,094,973,875.48, down from RMB 1,294,974,489.10 as of December 31, 2021, indicating a decrease of 15.4%[15] - The equity attributable to shareholders as of March 31, 2022, was RMB 1,869,462,329.76, an increase from RMB 1,842,642,358.23 as of December 31, 2021, reflecting a growth of 1.5%[16] - The total liabilities decreased marginally to CNY 1,184,994,967.35 in Q1 2022 from CNY 1,187,841,073.55 in Q4 2021, indicating stable financial leverage[26] Research and Development - Research and development expenses for Q1 2022 amounted to RMB 61,524,942.39, compared to RMB 56,136,909.62 in Q1 2021, indicating an increase of 9.5%[17] - R&D expenses increased to CNY 59,530,168.12 in Q1 2022, up 26.8% from CNY 46,933,172.66 in Q1 2021, reflecting the company's commitment to innovation[27] Shareholder Information - The top ten shareholders collectively hold 49.86% of the company's shares, with the largest individual shareholders each holding 9.19%[10] Market Strategy - The company has not indicated any new product launches or significant market expansion strategies in the current report[12] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[27]